These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25772236)

  • 21. Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein.
    Wimmer P; Blanchette P; Schreiner S; Ching W; Groitl P; Berscheminski J; Branton PE; Will H; Dobner T
    Oncogene; 2013 Mar; 32(13):1626-37. PubMed ID: 22614022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus E1B 55K represses p53 activation in vitro.
    Martin ME; Berk AJ
    J Virol; 1998 Apr; 72(4):3146-54. PubMed ID: 9525640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of p53 by adenovirus type 12 E1B-55K deregulates cell cycle control and sensitizes tumor cells to genotoxic agents.
    Li Q; Zhao LY; Zheng Z; Yang H; Santiago A; Liao D
    J Virol; 2011 Aug; 85(16):7976-88. PubMed ID: 21680522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.
    Shen Y; Kitzes G; Nye JA; Fattaey A; Hermiston T
    J Virol; 2001 May; 75(9):4297-307. PubMed ID: 11287579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-Protein Interactions Facilitate E4orf6-Dependent Regulation of E1B-55K SUMOylation in HAdV-C5 Infection.
    Fiedler M; Ip WH; Hofmann-Sieber H; Wilkens B; Nkrumah FK; Zhang W; Ehrhardt A; Bertzbach LD; Dobner T
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2.
    Krätzer F; Rosorius O; Heger P; Hirschmann N; Dobner T; Hauber J; Stauber RH
    Oncogene; 2000 Feb; 19(7):850-7. PubMed ID: 10702793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.
    Higginbotham JM; O'Shea CC
    J Virol; 2015 Oct; 89(20):10260-72. PubMed ID: 26223632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation.
    Baker A; Rohleder KJ; Hanakahi LA; Ketner G
    J Virol; 2007 Jul; 81(13):7034-40. PubMed ID: 17459921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif.
    Chalabi Hagkarim N; Ip WH; Bertzbach LD; Abualfaraj T; Dobner T; Molloy DP; Stewart GS; Grand RJ
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription.
    Martin ME; Berk AJ
    Mol Cell Biol; 1999 May; 19(5):3403-14. PubMed ID: 10207064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.
    Yew PR; Liu X; Berk AJ
    Genes Dev; 1994 Jan; 8(2):190-202. PubMed ID: 8299938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming potential of the adenovirus type 5 E4orf3 protein.
    Nevels M; Täuber B; Kremmer E; Spruss T; Wolf H; Dobner T
    J Virol; 1999 Feb; 73(2):1591-600. PubMed ID: 9882365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
    PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.
    O'Shea CC; Johnson L; Bagus B; Choi S; Nicholas C; Shen A; Boyle L; Pandey K; Soria C; Kunich J; Shen Y; Habets G; Ginzinger D; McCormick F
    Cancer Cell; 2004 Dec; 6(6):611-23. PubMed ID: 15607965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.
    Haupt S; Mitchell C; Corneille V; Shortt J; Fox S; Pandolfi PP; Castillo-Martin M; Bonal DM; Cordon-Cardo C; Lozano G; Haupt Y
    Cell Cycle; 2013 Jun; 12(11):1722-31. PubMed ID: 23656786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein.
    Endter C; Kzhyshkowska J; Stauber R; Dobner T
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11312-7. PubMed ID: 11553772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.
    Yang S; Jeong JH; Brown AL; Lee CH; Pandolfi PP; Chung JH; Kim MK
    J Biol Chem; 2006 Sep; 281(36):26645-54. PubMed ID: 16835227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.